antivir
peptid
avp
recent
emerg
altern
strategi
fight
diseas
caus
peptid
enfuvirtid
first
avp
approv
fda
similarli
sifuvirtid
sft
peptid
shown
potent
activ
pharmacokinet
profil
clinic
peptid
shown
potenc
human
papilloma
viru
hpv
infect
phase
ii
clinic
ctl
epitop
capabl
induc
cellular
humor
respons
phase
clinic
trial
hepat
c
viru
hcv
anoth
synthet
peptid
report
prevent
hiv
infect
evalu
antivir
properti
phase
ii
clinic
sinc
peptid
involv
number
cellular
process
consider
potenti
act
drug
treat
human
diseas
mani
drug
alreadi
gener
billion
dollar
annual
drug
like
penicillin
insulin
wide
use
antimicrobi
peptid
produc
live
organ
mean
defens
invad
microb
includ
bacteria
protozoa
fungi
virus
exampl
cathelicidin
defensin
histatin
late
antimicrobi
peptid
use
control
differ
type
pathogen
particularli
major
caus
malais
death
world
high
genet
variat
differ
rout
transmiss
effici
replic
capabl
persist
host
although
sever
tradit
antivir
nucleosid
analogu
virus
mani
drug
undesir
toxic
wherea
avp
natur
amino
acid
lesser
toxic
easili
elimin
avp
block
virus
via
differ
strategi
includ
inhibit
viru
fusion
signal
replic
interact
variou
glycosaminoglycan
cell
surfac
thu
compet
viru
attach
site
may
obstruct
viral
entri
bind
viru
fusion
protein
cellular
receptor
need
viru
intern
also
hinder
viral
gene
express
translat
via
inhibit
essenti
viral
protein
like
polymeras
revers
transcriptas
earliest
report
avp
describ
herp
simplex
viru
hsv
daher
report
avp
melittin
peptid
note
inhibitori
activ
junin
viru
jv
similarli
alloferon
peptid
demonstr
inhibit
influenza
peptid
deriv
human
lactoferricin
shown
possess
potent
antivir
activ
varieti
gener
efficaci
avp
measur
half
maxim
inhibitori
concentr
quantit
measur
signifi
concentr
molecul
drug
requir
block
given
biolog
process
half
exampl
flupep
block
influenza
viru
entri
cell
also
peptid
deriv
rhoa
protein
restrict
respiratori
syncyti
viru
rsv
replic
best
perform
peptid
accomplish
similarli
pinon
et
abl
inhibit
human
leukemia
viru
htlv
proteas
use
avp
minimum
also
ray
et
demonstr
abil
small
peptid
inhibit
hcv
translat
well
replic
disrupt
interact
proteas
hcv
ire
valu
although
avp
two
special
databas
hipdb
avpdb
avail
addit
avp
predict
algorithm
avppr
classifi
given
peptid
sequenc
effect
also
exist
howev
peptid
antivir
activ
predictor
term
valu
lack
therefor
studi
develop
algorithm
use
experiment
proven
dataset
employ
multipl
machin
learn
algorithm
combin
peptid
avail
recent
publish
special
avp
databas
select
peptid
quantit
valu
virus
remov
redund
sequenc
peptid
left
divid
dataset
peptid
trainingtest
peptid
independ
valid
peptid
length
rang
averag
amino
acid
residu
peptid
trainingtest
dataset
belong
divers
virus
quantit
valu
rang
valid
dataset
belong
virus
quantit
valu
rang
full
descript
trainingtest
valid
dataset
avail
web
server
well
support
inform
tabl
use
differ
featur
like
amino
acid
composit
binari
profil
physicochem
properti
solvent
access
secondari
structur
hybrid
model
develop
addit
also
use
databas
scan
techniqu
display
earlier
report
sequenc
match
user
provid
peptid
amino
acid
composit
wide
use
number
exist
predict
fraction
amino
acid
peptid
fraction
natur
amino
acid
calcul
use
follow
equat
fraction
amino
acid
xtotal
number
xpeptid
length
model
develop
use
mono
di
amino
acid
composit
term
mono
di
respect
mani
research
use
binari
method
predict
protein
peptid
belong
differ
binari
profil
gener
peptid
amino
acid
repres
vector
dimens
eg
ala
cy
etc
incorpor
posit
inform
amino
acid
peptid
pattern
window
length
w
repres
vector
dimens
w
model
creat
employ
binari
pattern
eight
carboxi
eight
amino
termin
amino
acid
refer
bin
bin
respect
gener
binari
pattern
eight
amino
acid
residu
sinc
minimum
length
peptid
dataset
number
worker
demonstr
import
physicochem
properti
develop
differ
type
predict
use
numer
valu
best
perform
physicochem
properti
support
inform
tabl
aaindex
databas
indic
defin
variou
physico
biochem
properti
amino
acid
pair
amino
model
develop
use
physicochem
featur
denot
physico
solvent
access
peptid
determin
extent
interact
solvent
proport
surfac
area
expos
solvent
access
peptid
predict
use
method
model
develop
use
solvent
access
featur
denot
sa
secondari
structur
peptid
depict
pattern
random
coil
secondari
structur
peptid
calcul
use
predict
psspred
modul
http
zhanglabccmbmedumichedupsspr
model
develop
use
secondari
structur
featur
denot
ss
sinc
sequenc
high
resembl
mimic
structur
function
similar
search
may
use
identifi
avp
approach
frequent
use
develop
protein
predict
method
queri
sequenc
match
two
newli
releas
avp
databas
viz
use
svm
use
develop
number
bioinformat
svmlight
softwar
packag
avail
http
svmlightjoachimsorg
use
construct
svm
model
studi
use
radial
basi
function
kernel
k
x
exp
x
two
data
vector
train
paramet
random
forest
rf
ensembl
learn
method
classif
randomforest
packag
version
r
avail
http
statwwwberkeleyeduusersbreimanrandomforest
use
ibk
neighbor
classifi
avail
weka
packag
access
http
wwwcswaikatoacnzmlweka
select
appropri
valu
k
base
distanc
weight
kstar
classifi
ibk
weka
packag
valu
test
instanc
base
upon
valu
train
instanc
similar
determin
similar
function
order
evalu
perform
model
use
pearson
correl
coeffici
pcc
model
evalu
use
leav
one
cross
valid
loocv
techniqu
pcc
eiact
eipr
n
size
test
set
eipr
eiact
predict
actual
respect
loocv
peptid
dataset
use
test
iter
rest
peptid
use
train
respect
predict
model
addit
loocv
also
use
leav
one
viru
cross
valid
lovocv
method
techniqu
avp
viru
iter
exclud
classifi
train
remain
viru
avp
follow
test
exclud
avp
individu
viru
model
develop
use
variou
peptid
sequenc
featur
includ
mono
acid
composit
binari
pattern
eight
amino
acid
physicochem
properti
forth
cross
valid
use
svm
achiev
maximum
correl
mono
di
physico
solvent
access
sa
secondari
structur
ss
model
respect
trainingtest
dataset
use
hybrid
model
mention
featur
perform
improv
maximum
case
composit
featur
shown
tabl
svm
rf
paramet
use
develop
predict
model
shown
support
inform
tabl
furthermor
calcul
differ
model
found
model
statist
signific
model
also
use
machin
learn
algorithm
like
rf
ibk
k
check
perform
trainingtest
data
use
mention
featur
rf
perform
similar
svm
best
pcc
hybrid
model
ibk
k
show
best
perform
hybrid
featur
tabl
howev
svm
perform
better
machin
learn
algorithm
besid
cross
valid
also
check
perform
model
independ
dataset
peptid
use
trainingtest
achiev
maximum
correl
mono
di
physico
solvent
access
sa
secondari
structur
ss
model
respect
use
svm
expect
hybrid
model
gave
better
correl
maximum
pcc
valu
hybrid
model
model
use
svm
machin
learn
techniqu
mlt
perform
similar
trend
correl
less
compar
svm
best
correl
hybrid
model
rf
ibk
k
tabl
correl
actual
predict
valu
independ
dataset
use
svm
rf
also
graphic
depict
figur
check
predict
perform
viru
avp
dataset
use
lovocv
method
tabl
overal
train
dataset
perform
cross
valid
rang
pcc
valu
minimum
maximum
averag
simultan
valid
perform
rang
pcc
averag
method
show
good
correl
virus
howev
virus
like
hiv
rsv
infv
hsv
perform
satisfactori
sinc
enough
avp
rsv
infv
hsv
avail
therefor
made
combin
dataset
virus
develop
predict
model
best
pcc
use
loocv
model
perform
well
pcc
independ
dataset
three
virus
also
develop
viru
specif
model
hiv
hcv
reason
number
peptid
avail
also
check
perform
method
use
loocv
techniqu
employ
earlier
mention
peptid
sequenc
featur
tabl
method
use
specif
avp
dataset
belong
hiv
avp
hcv
avp
individu
divid
train
valid
dataset
keep
data
valid
case
also
perform
increas
use
hybrid
bin
featur
pcc
compar
individu
featur
pcc
two
sampl
logo
use
graphic
depict
differ
two
set
sequenc
tool
freeli
avail
via
url
http
wwwtwosamplelogoorg
highli
least
effect
avp
chosen
gener
two
sampl
logo
use
residu
valu
highli
least
effect
avp
respect
n
termin
region
found
larg
acid
amino
acid
like
met
thr
asp
glu
enrich
highli
effect
avp
small
basic
amino
acid
like
ala
gli
ly
common
least
effect
avp
figur
similarli
region
larg
polar
amino
acid
like
leu
trp
asn
frequent
highli
effect
avp
small
posit
charg
amino
acid
like
gli
ly
arg
common
least
effect
avp
figur
b
two
sampl
logo
sequenc
differ
amino
acid
color
per
charg
hydrophob
surfac
exposur
flexibl
disord
avail
support
inform
figur
box
plot
conveni
way
denot
summari
statist
distribut
numer
data
allow
depict
maximum
minimum
median
data
set
also
visual
lower
upper
select
highli
effect
equal
number
least
effect
avp
calcul
best
perform
physicochem
properti
support
inform
tabl
predict
svm
box
plot
individu
properti
drawn
use
boxplotr
avail
http
boxplottyerslabcom
plot
shown
support
inform
figur
ii
observ
properti
like
helix
initi
paramet
c
frequenc
non
beta
region
free
energi
region
e
frequenc
helix
f
k
discrimin
compar
other
similar
result
report
chang
polanco
et
analyz
physicochem
properti
avp
submit
page
user
may
past
singl
multipl
peptid
sequenc
fasta
format
provid
upload
fasta
file
system
exampl
link
provid
load
default
set
sequenc
user
select
desir
model
mlt
run
predict
support
inform
figur
predict
output
shown
tabular
form
column
first
second
third
column
consist
sequenc
identifi
input
fasta
sequenc
sequenc
sequenc
length
respect
fourth
column
give
action
button
databas
scan
order
check
presenc
similar
sequenc
exist
antivir
databas
hipdb
avpdb
also
latest
uniprot
releas
use
blast
rest
column
show
output
differ
mlt
use
studi
svm
rf
ibk
k
predict
valu
peptid
sequenc
display
unit
analysi
column
display
calcul
physicochem
properti
peptid
question
column
tabl
provid
sort
function
search
option
also
provid
filter
result
figur
tool
allow
user
gener
possibl
combin
amino
acid
mutat
given
peptid
sequenc
predict
mutant
peptid
use
best
perform
model
howev
mutat
peptid
comput
predict
need
experiment
valid
work
exampl
provid
tabl
user
may
blast
peptid
similar
hipdb
avpdb
result
show
distribut
hit
score
align
sequenc
signific
similar
map
tool
use
fetch
perfectli
match
peptid
avail
exist
avp
databas
map
user
provid
protein
sequenc
result
output
display
list
earlier
report
avp
match
specif
portion
user
provid
sequenc
properti
tool
allow
user
visual
examin
import
peptid
featur
like
amino
acid
composit
hydrophob
prefer
frequenc
given
peptid
sequenc
motif
scan
allow
search
possibl
avp
motif
user
provid
proteinpeptid
sequenc
tool
base
mememast
tool
gener
peptid
fragment
desir
length
overlap
residu
protein
sequenc
check
conserv
user
provid
peptid
sequenc
human
viral
antivir
protein
use
mutat
analyz
user
gener
possibl
combin
amino
acid
mutat
given
peptid
sequenc
predict
mutant
peptid
tool
also
enabl
user
sort
mutant
peptid
per
predict
valu
select
highli
effect
peptid
exampl
gener
mutant
hiv
fusion
inhibitor
use
tool
found
mutat
like
improv
predict
hundr
fold
likewis
mutat
peptid
alter
fold
similar
analysi
peptid
also
carri
provid
tabl
due
limit
avail
drug
vaccin
mani
virus
demand
develop
effect
antivir
thu
apart
drug
vaccin
avp
potenti
altern
control
viral
lower
toxic
broad
rang
avp
eb
peptid
cytomegaloviru
cmv
sft
human
neutrophil
peptid
forth
shown
promis
result
high
specif
rel
avp
act
via
varieti
rout
includ
inhibit
viral
entri
host
cell
suppress
viral
gene
express
translat
immunopotenti
antivir
activ
peptid
often
determin
experiment
half
maxim
inhibitori
concentr
valu
usual
avp
valu
consid
effect
least
effect
repress
viral
process
function
although
mani
antimicrobi
peptid
predict
server
like
wang
et
forth
one
avp
predictor
base
classif
mode
machin
learn
classifi
peptid
sequenc
effect
ineffect
addit
none
quantit
predict
antimicrobi
antivir
activ
peptid
term
develop
predictor
extract
comprehens
avp
quantit
valu
special
resourc
avp
randomli
divid
three
trainingtest
valid
dataset
belong
mani
medic
import
virus
also
check
perform
svm
model
base
three
train
valid
dataset
select
one
set
better
perform
algorithm
develop
shown
support
inform
tabl
antivir
act
mani
differ
way
howev
gener
avp
act
via
interfer
interact
mimick
properti
one
interfac
thu
act
competit
inhibitor
prevent
interact
bind
protein
partner
variou
sequenc
featur
peptid
play
import
role
bioactiv
featur
includ
amino
acid
composit
nc
termin
residu
physicochem
properti
like
hydrophob
secondari
structur
forth
also
report
previous
predict
import
peptid
viz
forth
evan
et
also
describ
hiv
coreceptor
tropism
predict
basi
site
physiochem
characterist
loop
sequenc
hiv
envelop
result
howev
found
svm
rf
compar
perform
better
ibk
k
mlt
mlt
svm
choos
appropri
kernel
gener
grade
svm
gain
flexibl
robust
deliv
uniqu
solut
rf
comput
proxim
pair
case
use
cluster
locat
outlier
rf
fast
highli
accur
learn
algorithm
handl
thousand
input
variabl
without
variabl
ibk
k
simpl
mlt
work
well
basic
recognit
problem
one
shortcom
two
algorithm
lazi
learner
learn
anyth
train
data
simpli
use
train
data
predict
robust
predict
noisi
due
reason
svm
rf
perform
better
mlt
studi
algorithm
employ
hybrid
model
integr
differ
peptid
featur
like
amino
acid
composit
binari
profil
physicochem
properti
forth
claim
method
first
ever
attempt
predict
numer
antivir
efficaci
valu
given
peptid
use
svm
first
place
predict
peptid
valu
achiev
maximum
pcc
cross
valid
pcc
independ
dataset
sinc
avp
heterogen
term
target
virus
one
import
question
remain
whether
algorithm
applic
gener
virus
found
earlier
research
given
class
peptid
follow
certain
pattern
case
antimicrobi
peptid
predict
algorithm
like
forth
address
issu
use
lovocv
avp
viru
iter
exclud
classifi
train
avp
remain
virus
follow
test
exclud
avp
approach
work
virus
predict
perform
viru
satisfactori
virus
despit
fact
data
includ
train
show
act
gener
avp
predict
algorithm
may
appli
virus
well
howev
except
like
hiv
rsv
infv
hsv
algorithm
work
due
fact
virus
differ
manner
infectionlif
cycl
henc
mechan
mode
action
avp
may
differ
case
therefor
provid
viru
specif
model
virus
also
integr
web
server
futur
interest
make
target
specif
algorithm
appropri
enough
data
avail
report
literatur
predict
method
develop
regress
mode
show
lower
correl
heterogen
dataset
homogen
dataset
exampl
similar
studi
sirna
found
pcc
rang
heterogen
dataset
increas
homogen
svm
model
studi
develop
use
highli
divers
dataset
taken
differ
studi
test
cell
line
virus
pcc
regress
mode
reason
perform
improv
larg
homogen
dataset
avail
futur
howev
put
confid
present
predict
use
three
mlt
addit
svm
name
rf
ibk
k
perform
similar
fashion
also
encourag
develop
newer
algorithm
besid
exist
method
area
therapeut
limit
report
experiment
improv
valu
avp
overcom
viru
resist
amino
acid
substitut
izumi
et
design
enfuvirtid
variant
contain
substitut
show
potent
inhibitor
enfuvirtid
enfuvirtid
virus
also
shown
mutat
four
amino
acid
wnwf
anaa
enfuvirtid
peptid
made
dwyer
et
found
mutat
increas
peptid
helic
structur
effect
block
viru
improv
peptid
efficaci
achiev
consider
effort
term
time
cost
algorithm
gener
possibl
mutant
potenti
avp
predict
efficaci
result
might
achiev
lesser
time
simultan
avp
improv
efficaci
might
use
mutat
virus
assist
research
direct
mutat
analyz
tool
use
design
avp
enhanc
antivir
potenti
illustr
applic
section
predict
analysi
singl
mutant
avp
dataset
provid
web
server
besid
web
server
also
equip
import
tool
physicochem
properti
calcul
motif
scan
blast
conserv
map
fragment
tool
analysi
avp
first
algorithm
develop
use
experiment
valid
data
set
predict
peptid
antivir
activ
term
multipl
mlt
use
build
comprehens
predict
model
exploit
import
peptid
sequenc
featur
amino
acid
dipeptid
composit
binari
profil
residu
well
select
physicochem
properti
web
server
hope
assist
research
work
avp
therapeut
decreas
cost
time
effort
involv
experiment
valid
mk
conceiv
approach
help
analysi
interpret
data
gave
overal
supervis
project
mk
aq
wrote
manuscript
aq
ht
collect
data
implement
machin
learn
softwar
develop
web
server
author
read
approv
final
manuscript
author
declar
compet
interest
